- Report
- October 2024
- 193 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- April 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 250 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- September 2023
- 188 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2022
- 40 Pages
India
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 80 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- January 2022
- 40 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Japan
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Russia
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- December 2022
- 240 Pages
Global
From €3394EUR$3,570USD£2,851GBP
- Book
- August 2022
- 672 Pages

Patient Blood Management (PBM) is a medical strategy that focuses on optimizing the care of patients who require blood transfusions. It is a multidisciplinary approach that involves the use of evidence-based practices to reduce the need for allogeneic blood transfusions, while ensuring the safety of the patient. PBM includes strategies such as preoperative anemia management, intraoperative blood salvage, and the use of alternative blood products. It also involves the use of blood conservation techniques such as cell salvage, erythropoietin, and iron supplementation.
PBM is an important part of blood banking, as it helps to reduce the demand for allogeneic blood transfusions and improve patient outcomes. It is also beneficial to blood banks, as it helps to reduce the cost of blood products and improve the efficiency of the blood supply.
Some companies in the PBM market include Fresenius Kabi, Haemonetics Corporation, Terumo BCT, and Grifols. Show Less Read more